Proteomic and oxidative stress analysis in human brain samples of Huntington disease

dc.contributor.author
Sorolla Bardají, Maria Alba
dc.contributor.author
Reverter Branchat, Gemma
dc.contributor.author
Tamarit Sumalla, Jordi
dc.contributor.author
Ferrer, Isidre
dc.contributor.author
Ros Salvador, Joaquim
dc.contributor.author
Cabiscol Català, Elisa
dc.date.accessioned
2024-12-05T21:21:13Z
dc.date.available
2024-12-05T21:21:13Z
dc.date.issued
2016-06-06T10:32:52Z
dc.date.issued
2025-01-01
dc.date.issued
2008
dc.identifier
https://doi.org/10.1016/j.freeradbiomed.2008.05.014
dc.identifier
0891-5849
dc.identifier
http://hdl.handle.net/10459.1/57161
dc.identifier.uri
http://hdl.handle.net/10459.1/57161
dc.description.abstract
Huntington disease (HD) is a neurodegenerative disorder caused by expansion of CAG repeats in exon 1 of the huntingtin gene, affecting initially the striatum and progressively the cortex. This work reports a proteomic analysis of human brain postmortem samples obtained from striatum and cortex of patients with HD compared to samples of age- and sex-matched controls. Antioxidant defense proteins that were strongly induced in striatum, but also detectable in cortex, were identified as peroxiredoxins 1, 2, and 6, as well as glutathione peroxidases 1 and 6. The activities of other antioxidant enzymes such as mitochondrial superoxide dismutase and catalase were also increased in HD. Aconitase, a protein involved in energy metabolism, showed decreased activities in striatum of HD patients. Protein carbonyls, used as markers of oxidative stress, were increased in HD, and glial fibrillary acidic protein, aconitase, γ-enolase, and creatine kinase B were identified as the main targets. Taken together, these results indicate that oxidative stress and damage to specific macromolecules would participate in the disease progression. Also, these data support the rationale for therapeutic strategies that either potentiate antioxidant defenses or avoid oxidative stress generation to delay disease progression.
dc.description.abstract
This work has been supported by Grants BFU2004-00593/BMC, BFU2007-66249, and CSD2007-20 Consolider Ingenio 2010 from the Ministerio de Educación y Ciencia (Spain) and SGR2005-00677 from the Generalitat de Catalunya. M. A. Sorolla is the recipient of a Ph.D. fellowship from the Ministerio de Educación y Ciencia (Spain)
dc.language
eng
dc.publisher
Elsevier
dc.relation
MIECI/PN2004-2007/BFU2004-00593/BMC
dc.relation
MIECI/PN2004-2007/BFU2007-66249
dc.relation
Reproducció del document publicat a https://doi.org/10.1016/j.freeradbiomed.2008.05.014
dc.relation
Free Radical Biology and Medicine, 2008, vol. 45, núm. 5, p. 667-678
dc.rights
(c) Elsevier Inc., 2008
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.subject
Huntington disease
dc.subject
Proteomic analysis
dc.subject
Oxidative stress
dc.subject
Protein carbonylation
dc.title
Proteomic and oxidative stress analysis in human brain samples of Huntington disease
dc.type
article
dc.type
publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)